Therefore, this prospective study compared serum UCH‐L1 levels in patients with and without cognitive impairment following AOPP to evaluate the utility of UCH‐L1 for the prediction of cognitive impairment. This evidence concerns the gene UCHL1 and Cognitive impairment.